Symbol="CLSD"
AssetType="Common Stock"
Name="Clearside Biomedical Inc"
Description="Clearside Biomedical, Inc., a biopharmaceutical company, is dedicated to developing and delivering treatments that restore and preserve vision for people with serious eye diseases. The company is headquartered in Alpharetta, Georgia."
CIK="1539029"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GE"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="58309000"
EBITDA="-29577000"
PERatio="None"
PEGRatio="0"
BookValue="-0.081"
DividendPerShare="0"
DividendYield="0"
EPS="-0.59"
RevenuePerShareTTM="0.027"
ProfitMargin="0"
OperatingMarginTTM="-18.34"
ReturnOnAssetsTTM="-0.53"
ReturnOnEquityTTM="-3.539"
RevenueTTM="1618000"
GrossProfitTTM="1123000"
DilutedEPSTTM="-0.59"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.651"
AnalystTargetPrice="5.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.639"
PriceToBookRatio="3.927"
EVToRevenue="0.744"
EVToEBITDA="-4.828"
Beta="2.102"
num_52WeekHigh="1.85"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.138"
num_200DayMovingAverage="1.19"
SharesOutstanding="62030000"
DividendDate="None"
ExDividendDate="None"
symbol="CLSD"
open="0.93"
high="0.95"
low="0.93"
price="0.94"
volume="69558.00"
latest_trading_day="2023-08-25"
previous_close="0.93"
change="0.01"
change_percent="1.0753%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="32"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="152821"
Change_recent_avg="0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.38"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_negative_thumbnail_id_2="1103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="654"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_positive_thumbnail_id_2="997"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0159.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
